Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Maxim Group Upgrades NLS Pharmaceutics to Buy, Announces $4 Price Target

Maxim Group analyst Jason McCarthy upgrades NLS Pharmaceutics (NASDAQ:NLSP) from Hold to Buy and announces $4 price target.
byBenzinga Newsdesk
December 8, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Maxim Group analyst Jason McCarthy upgrades NLS Pharmaceutics (NASDAQ:NLSP) from Hold to Buy and announces $4 price target.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Retractable Technologies And 3 Other Stocks Under $3 Insiders Are Buying

By Avi Kapoor
January 5, 7:55 AM
The Dow Jones index closed higher by around 10 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

CDZI